Are We Ready For Psychiatric BCI?

Inner Cosmos is a startup reinventing care for depressed patients unresponsive to conventional pharmaceutical therapies. Since the FDA granted the company a device exemption to initiate a feasibility study in 2022, they have fitted three patients with their Digital Pill device. This makes the company an early first mover in psychiatric brain-computer interfaces and ushers in a new era for the BCI field.

Writing new brain chemistry at the push of a button is not a new idea. Deep brain…